Here are a few of the most interesting Illumina statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
- Website: Official Website
- Year Founded: 1998
- Headquarters: San Diego, CA
- Founder(s): David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik and Mark Chee
- Current Chief Executive: Francis deSouza
What is Illumina?
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. (source)
Illumina Employee Count
Number of Illumina employees:
Last updated 1/1/20
Number of Illumina patents:
Last updated 1/16/20
Get the Full Industry Report
This full report is available in an annual industry report. Some of the data in industry reports include:
- Company Quick Facts
- Employee Counts
- Income and Revenue Totals
- Etc.- all in one place
I try to go through each and every stat regularly and update as much as possible, but we all know that some stats are easier to track down than others. As always, every stat is linked to its original source and has the source date listed.
To get your copy of the report, click on the button below to purchase it.
Report 1: Biopharma Industry Report ( Abbott, Abbvie, Allergan, Amgen, Astellas, AstraZeneca, Bayer, Biogen, Bristol-Myers Squibb, Eli Lilly, Gilead, GlaxoSmithKline, Illumina, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, Stryker, Takeda, Vertex and Zoetis).